FDA Inspection Readiness Consulting for Biopharma

Q: How are FDA PLI and PAI inspections different from surveillance inspections?

PLI and PAI inspections are tied to FDA application review and approval decisions. They focus on whether the site, processes, data, and controls support licensure or approval, and whether the facility is ready for commercial manufacturing as described in the application. Surveillance inspections are different: they are routine GMP inspections of ongoing operations and focus on whether the manufacturer continues to comply with CGMP in a sustained state of control.

Q: Can GMP Bridge support FDA PLI and PAI readiness programs?

Yes. We support biopharma companies with targeted FDA readiness programs for PLIs and PAIs, including gap assessments, mock inspections, SME preparation, document flow readiness, and leadership support before and during inspection.

Q: Do you perform FDA-style mock inspections?

Yes. GMP Bridge performs FDA-style mock inspections designed to test how the site, systems, and teams perform under realistic inspection conditions. The objective is to identify vulnerabilities early, challenge weak narratives, and focus remediation on the issues most likely to matter to FDA investigators.

Q: Can GMP Bridge help us respond to FDA 483 observations?

Yes. We support companies in preparing structured, credible, and risk-based responses to FDA 483 observations. This includes helping assess the broader systemic issue behind the observation, define effective CAPAs, and build responses that stand up to regulatory scrutiny.

Q: Do you also support FDA remediation programs after major findings?

Yes. We support remediation programs following 483s, warning letter exposure, failed inspections, or broader FDA readiness concerns. Our role can include remediation strategy, Quality system strengthening, execution support, governance, and follow-up to help the organization return to a more defensible state of control.

FDA Inspection Readiness and Mock Audits

Health Authorities Inspection Readiness

Preparing your organization for FDA and EMA inspections

We provide FDA inspection readiness consulting that equips biotech and advanced therapy companies to face U.S. and EMA regulators with confidence. From Pre-Approval Inspections (PAIs) to routine audits and 483 remediation, inspections are high-stakes moments that can define your future.

We prepare your teams, systems, and sites through mock inspections, dossier and SOP reviews, and live coaching before, during, and after inspections. With the right experts, FDA readiness becomes more than compliance — it becomes an opportunity to strengthen systems, accelerate approvals, and build lasting trust with regulators and investors.

Compliance gaps often only become visible under inspection pressure

Inspection pressure make compliance gaps visible

Many organizations believe they are inspection-ready until they are tested. Gaps in documentation, inconsistent processes and unclear responsibilities often become visible only during inspections, leading to observations, delays, and regulatory risk.

Without structured preparation, inspections become reactive and high-risk events instead of controlled and manageable processes.

What we offer

Structured Inspection Readiness

GMP Bridge supports you in preparing for regulatory inspections through structured assessments, targeted remediation, and hands-on coaching. We focus on identifying critical gaps early, strengthening your systems, and ensuring your organization is ready to perform under real inspection conditions.

Our approach transforms inspections from high-risk events into structured and manageable processes — with clear responsibilities, aligned teams, and confident execution.

Gap Assessment & Readiness Check

Structured assessment of your current GMP setup to identify compliance gaps, weaknesses, and inspection risks.

Remediation Planning & Execution

Prioritized action plans to address findings, close gaps, and strengthen critical systems and processes.

Mock Inspections & Coaching

Realistic, FDA-style mock inspections combined with coaching to prepare teams for inspection scenarios.

Inspection Support & Response

Hands-on support during inspections, including preparation, communication and response to observations.

Confidence, control, and readiness under inspection pressure

What You Achieve

Structured inspection readiness ensures your organization is prepared to perform under real regulatory conditions. It reduces uncertainty, strengthens control, and enables confident, well-coordinated inspection execution.

Inspection Confidence

Prepared teams that know what to expect and how to respond

Reduced Risk of Findings

Fewer observations through proactive gap closure and preparation

Clear Roles & Communication

Aligned teams with defined responsibilities during inspections

Controlled Execution

Structured, calm and professional handling of inspection scenarios

Be Ready for Your Next InspectionLet's talk!

Schedule your call

FAQs

Frequently Asked Questions

How are FDA PLI and PAI inspections different from surveillance inspections?

Can GMP Bridge support FDA PLI and PAI readiness programs?

Do you perform FDA-style mock inspections?

Can GMP Bridge help us respond to FDA 483 observations?

Do you also support FDA remediation programs after major findings?